Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
[<sup>68</sup>Ga]Ga-PSMA PET could be a useful imaging tool for monitoring response to enzalutamide in mCRPC patients, being more informative than PSA in this setting, and possibly better guiding clinicians in therapeutic decisions.
Authors
- Emanuela Scarpi (ORCID: https://orcid.org/0000-0001-7230-9267)
- Irene Marini (ORCID: https://orcid.org/0009-0002-6186-688X)
- Cristian Lolli (ORCID: https://orcid.org/0000-0003-0347-9179)
- Virginia Rossetti (ORCID: https://orcid.org/0000-0001-6052-8729)
- Amelia Altavilla (ORCID: https://orcid.org/0000-0002-1598-9451)
- Giuseppe Schepisi (ORCID: https://orcid.org/0000-0002-9973-4869)
- Paola Caroli
- Federica Matteucci (ORCID: https://orcid.org/0000-0001-7455-6253)
- Giovanni Paganelli (ORCID: https://orcid.org/0000-0002-2631-4652)
- Maria Concetta Cursano (ORCID: https://orcid.org/0000-0001-5064-3950)
- Ugo De Giorgi (ORCID: https://orcid.org/0000-0001-7520-2908)
- Sara Bleve (ORCID: https://orcid.org/0009-0008-2704-1423)
- Nicole Brighi (ORCID: https://orcid.org/0000-0002-1187-5481)
- Monica Celli (ORCID: https://orcid.org/0000-0002-0338-800X)
- Emilio Francesco Giunta (ORCID: https://orcid.org/0000-0002-5383-4469)
- Chiara Casadei (ORCID: https://orcid.org/0000-0003-2467-749X)
Institutions
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1007/s00259-024-06887-4
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26